Aphria Inc. announced earnings results for the second quarter ended November 30, 2017. For the quarter, the company reported revenue of CAD 8,504,000 against CAD 5,227,000 a year ago. Net income was CAD 6,455,000 against CAD 945,000 a year ago. Adjusted EBITDA from operations was CAD 1,621,000 against CAD 1,199,000 a year ago. The increase in revenue from the same period in the prior year was largely related to continued growth of both wholesale shipments and sales to existing patients, as well as continued acceleration of patient onboarding and an increased average selling price (excluding wholesale).